---
figid: PMC9588789__41467_2022_34024_Fig7_HTML
figtitle: Schema depicting the BET inhibitor resistance in PCa cells due to RB loss
  and hyperphosphorylation
organisms:
- Nicotiana tabacum
- Bikinia letestui
- Homo sapiens
- Mus musculus
- vectors
- Escherichia coli BL21
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC9588789
filename: 41467_2022_34024_Fig7_HTML.jpg
figlink: /pmc/articles/PMC9588789/figure/Fig7/
number: F7
caption: RB binds to the BD1 of BRD4 and impedes BRD4 targeting of chromatin. However,
  RB loss or phosphorylation by CDKs such as CDK4/6 augments BRD4 occupancy on chromatin
  at genomic loci such as genes in the GPCR-cAMP signaling pathway, thereby leading
  to aberrant activation of CREB and BET inhibitor resistance. The resistance can
  be overcome by co-targeting of CREB, representing a vulnerability for BET inhibitors
  in RB-deficient cancer cells.
papertitle: Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small
  molecule BET inhibitor sensitivity in cancer.
reftext: Donglin Ding, et al. Nat Commun. 2022;13:6311.
year: '2022'
doi: 10.1038/s41467-022-34024-y
journal_title: Nature Communications
journal_nlm_ta: Nat Commun
publisher_name: Nature Publishing Group UK
keywords: Prostate cancer | Cancer therapeutic resistance | Gene regulation
automl_pathway: 0.949155
figid_alias: PMC9588789__F7
figtype: Figure
redirect_from: /figures/PMC9588789__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9588789__41467_2022_34024_Fig7_HTML.html
  '@type': Dataset
  description: RB binds to the BD1 of BRD4 and impedes BRD4 targeting of chromatin.
    However, RB loss or phosphorylation by CDKs such as CDK4/6 augments BRD4 occupancy
    on chromatin at genomic loci such as genes in the GPCR-cAMP signaling pathway,
    thereby leading to aberrant activation of CREB and BET inhibitor resistance. The
    resistance can be overcome by co-targeting of CREB, representing a vulnerability
    for BET inhibitors in RB-deficient cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Defb1
  - Defb2
  - Igkv1-135
  - Brd4
  - ac
  - Cdk6
  - Cdk4
  - Creb1
  - Ptprj
  - Dner
  - Gnb1l
  - Gpbar1
  - DEFB1
  - DEFB4A
  - BRD4
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - CDK6
  - CDK4
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - DNER
  - GNB1L
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - MTG1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - defbl2
  - brd4
  - cdk6
  - cdk4
  - gnb1l
  - gnb1b
---
